Excessive tear evaporation is a key driver in dry eye disease. But while current prescription treatment options can address the symptoms of 2 out of 3 contributing factors to dry eye disease (aqueous deficiency and inflammation)—a need remains for effectively treating excessive tear evaporation.

This White Paper will help practitioners understand the evaporative etiology of DED and the cycle of ocular surface damage and inflammation that chronically persists in patients with evaporative dry eye. Read on to learn why the development of prescription anti-evaporative drop therapies is imperative in the successful treatment of this major root cause of dry eye disease.

Sponsored By